A Double-Blind, Vehicle Controlled, Randomized, Phase II Study of SR-T100 Gel on External Genital Warts/Condyloma Acuminate (EGWs)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2017
At a glance
- Drugs SR T100 (Primary)
- Indications Condylomata acuminata
- Focus Therapeutic Use
- Sponsors G&E Herbal Biotechnology
- 01 Jun 2017 Planned number of patients changed from 130 to 111.
- 01 Jun 2017 Planned End Date changed from 1 Nov 2017 to 1 Jun 2018.
- 01 Jun 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Apr 2018.